General Information of the Compound
| Compound ID |
CP0465994
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-((5-(3,5-dichlorophenyl)-3-(4-(trifluoromethoxy)phenyl)-1H-pyrazol-1-yl)methyl)-N-(2H-tetrazol-5-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H16Cl2F3N7O2
|
||||||||||||||||||
| Molecular Weight |
574.35
|
||||||||||||||||||
| Canonical SMILES |
FC(F)(F)Oc1ccc(cc1)-c1cc(-c2cc(Cl)cc(Cl)c2)n(Cc2ccc(cc2)C(=O)Nc2nnn[nH]2)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H16Cl2F3N7O2/c26-18-9-17(10-19(27)11-18)22-12-21(15-5-7-20(8-6-15)39-25(28,29)30)34-37(22)13-14-1-3-16(4-2-14)23(38)31-24-32-35-36-33-24/h1-12H,13H2,(H2,31,32,33,35,36,38)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GZYITZKAMSNQMT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02242, Gastric inhibitory polypeptide receptor
Protein ID: PT01473, Glucagon receptor